首页> 外文OA文献 >Pretargeted Radioimmunotherapy Using an Anti-CD45 Antibody-Streptavidin Conjugate and Radiolabeled DOTA-Biotin in Patients with High-Risk Acute Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation

【2h】

Pretargeted Radioimmunotherapy Using an Anti-CD45 Antibody-Streptavidin Conjugate and Radiolabeled DOTA-Biotin in Patients with High-Risk Acute Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation

机译：在患有异基因造血细胞移植的高危急性白血病或骨髓增生异常综合症患者中，使用抗CD45抗体-链霉亲和素结合物和放射性标记的DOTA-生物素进行预靶向放射免疫治疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Mawad Raya; Gooley Ted; Rajendran Joseph G.; Fisher Darrell R.; Shields Andrew; Orozco Johnnie J.; Hamlin Donald K.; Wilbur D. Scott; Hylarides Mark D.; Gopal Ajay K.; Green Damian J.; Maloney David G.; Sandmaier Brenda M.; Storb Rainer F.; Appelbaum Frederick R.; Press Oliver W.; Pagel John M.;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Radiolabeled anti-CD45 antibody with reduced-intensity conditioning and allogeneic transplantation for younger patients with advanced acute myeloid leukemia or myelodysplastic syndrome [J] . MawadR., GooleyT.A., RajendranJ.G., Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2014,第9期

机译：降低强度的条件和同种异体移植的放射性标记抗CD45抗体，用于年轻的晚期急性髓样白血病或骨髓增生异常综合征患者
2. Decitabine-Containing Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Intermediate- and High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia: Potential Decrease in the Incidence of Acute Graft versus Host Disease [J] . Qing Ya Wang, Yuan Li, Ze Yin Liang, Cancer Management and Research . 2019,第4期

机译：含有异种造血干细胞移植患者的含离菜的调理方案，中间和高危骨髓增生综合征/急性髓性白血病：急性移植物发生率的潜在降低与宿主病
3. Allogeneic Hematopoietic Cell Transplantation in Patients Age 60-70 Years with De Novo High-Risk Myelodysplastic Syndrome or Secondary Acute Myelogenous Leukemia: Comparison with Patients Lacking Donors Who Received Azacitidine [J] . PlatzbeckerU., ScheteligJ., FinkeJ., Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2012,第9期

机译：De Novo高危骨髓增生异常综合症或继发性急性粒细胞白血病的60-70岁患者的同种异体造血细胞移植：与缺乏接受阿扎胞苷的捐助者的比较
4. Extraorally delivered photobiomodulation therapy for prevention of oropharyngeal mucositis in pediatric patients undergoing hematopoietic cell transplantation [C] . Christine N. Duncan, Anna N. Yaroslavsky, Wendy B. London, Mechanisms of photobiomodulation therapy XII . 2017

机译：外用光生物调节疗法预防小儿造血细胞移植患者的口咽粘膜炎
5. Donor selection for patients undergoing allogeneic hematopoietic stem cell transplantation: Assessment of the priorities of Canadian hematopoietic stem cell transplant physicians. [D] . Tay, Jason. 2009

机译：接受同种异体造血干细胞移植的患者的供体选择：加拿大造血干细胞移植医生的优先事项评估。
6. Clinical Trials and Observations: Allogeneic hematopoietic cell transplantation after conditioning with 131I–anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome [O] . John M. Pagel, Theodore A. Gooley, Joseph Rajendran, -1

机译：临床试验和观察：老年晚期急性髓样白血病或高危骨髓增生异常综合征患者接受131I-抗CD45抗体加氟达拉滨和低剂量全身照射后进行同种异体造血细胞移植
7. Allogeneic hematopoietic cell transplantation after conditioning with 131I–anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome [O] . Pagel, John M., Gooley, Theodore A., Rajendran, Joseph, 2009

机译：老年急性急性髓细胞白血病或高危骨髓增生异常综合征患者接受131I-抗CD45抗体加氟达拉滨和低剂量全身照射后的同种异体造血细胞移植

Pretargeted Radioimmunotherapy Using an Anti-CD45 Antibody-Streptavidin Conjugate and Radiolabeled DOTA-Biotin in Patients with High-Risk Acute Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation

著录项

相似文献

相关主题

期刊订阅